Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 3/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.57 |
| ▸ | MEN1 | O00255 | 2/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.57 |
| ▸ | THRB | P10828 | 1/20 | 0.57 |
| ▸ | BLM | P54132 | 1/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.46 |
| ▸ | TRIM24 | O15164 | 2/20 | 0.46 |
| ▸ | TRIM33 | Q9UPN9 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
| ▸ | CA9 | Q16790 | 1/20 | 0.40 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ERN1 | O75460 | 2/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30332152 | 1.00 | LMNA (0.57) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL10894910 | 0.80 | LMNA (0.57) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL14163613 | 0.79 | KMT2A (0.44) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL942936 | 0.78 | ALDH1A1 (0.44) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL28131003 | 0.78 | CA12 (0.39) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL13069600 | 0.78 | LMNA (0.55) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL17950685 | 0.78 | LMNA (0.55) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL11884139 | 0.78 | LMNA (0.55) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL12819701 | 0.78 | CA12 (0.39) | LMNAKMT2AMEN1TDP1THRB | |
| SCHEMBL13524726 | 0.78 | CDK4 (0.53) | LMNAKMT2AMEN1TDP1THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 287 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120617300-B | Application of BSP-MA/HA-NB hydrogel in preparation of medicines for treating bone defect, cartilage injury or articular cartilage degenerative diseases | Sichuan Orthopaedic Hospital (Chengdu Sports Hospital, Chengdu Sports Trauma Research Institute) (CN) | 2026-05-26 | — | — | CN | claimed |
| CN-119367547-A | Novel oral delivery microcarrier with intestinal tract adhesion function and preparation method thereof | 浙江大学医学院附属邵逸夫医院 | 2025-01-28 | — | — | CN | claimed |
| CN-114573635-B | Photocrosslinking probe and mitochondrial protein enrichment method based on photocrosslinking | 中国科学院大连化学物理研究所 | 2024-01-30 | — | — | CN | claimed |
| CN-114931629-A | Application of biological gelatin modified by o-nitrosobenzaldehyde group in preparation of drugs for preventing or treating inflammatory bowel diseases | 浙江大学医学院附属邵逸夫医院 | 2022-08-23 | — | — | CN | claimed |
| CN-114573635-A | Photo-crosslinking probe and mitochondrial protein enrichment method based on photo-crosslinking | 中国科学院大连化学物理研究所 | 2022-06-03 | — | — | CN | claimed |
| US-7539006-B2 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2009-05-26 | — | — | US | claimed |
| US-20070029529-A1 | Electrolytic solution for driving electrolytic capacitor and electrolytic capacitor | KOMATSU AKIHIKO | 2007-02-08 | — | — | US | claimed |
| US-20040245105-A1 | Electrolyte solution for driving electrolytic capacitor and electrolytic capacitor | RUBYCON CORPORATION (JP) | 2004-12-09 | — | — | US | claimed |
| EP-1437749-A1 | ELECTROLYTE SOLUTION FOR DRIVING ELECTROLYTIC CAPACITOR AND ELECTROLYTIC CAPACITOR | Rubycon Corporation (JP) | 2004-07-14 | — | — | EP | claimed |
| CN-120617300-B | Application of BSP-MA/HA-NB hydrogel in preparation of medicines for treating bone defect, cartilage injury or articular cartilage degenerative diseases | Sichuan Orthopaedic Hospital (Chengdu Sports Hospital, Chengdu Sports Trauma Research Institute) (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-120617300-B | Application of BSP-MA/HA-NB hydrogel in preparation of medicines for treating bone defect, cartilage injury or articular cartilage degenerative diseases | Sichuan Orthopaedic Hospital (Chengdu Sports Hospital, Chengdu Sports Trauma Research Institute) (CN) | 2026-05-26 | — | — | CN | disclosed |
| CN-122080358-A | Light-triggered self-healing aqueous polyurethane dispersion and preparation method and application thereof | — | 2026-05-26 | — | — | CN | disclosed |
| US-20260062400-A1 | SYSTEMS AND METHODS FOR THE SYNTHESIS OF HYDROXAMIC ACIDS | KENNESAW STATE UNIV RESEARCH AND SERVICE FOUNDATION INC (US) | 2026-03-05 | — | — | US | disclosed |
| CN-121490124-A | Photosensitive tissue sealant and preparation method and application thereof | 中国人民解放军陆军特色医学中心 | 2026-02-10 | — | — | CN | disclosed |
| US-5081000-A | PHOTOSENSITIVE MIXTURE | SIEMENS AKTIENGESELLSCHAFT (DE) | 1992-01-14 | — | — | US | disclosed |
| US-4996136-A | Radiation sensitive materials and devices made therewith | AT&T BELL LABORATORIES (US) | 1991-02-26 | — | — | US | disclosed |
| EP-0330386-A2 | Radiation sensitive materials and devices made therewith | AT&T Corp. (US) | 1989-08-30 | — | — | EP | disclosed |
| US-4740449-A | Optical recording medium | CANON KABUSHIKI KAISHA (JP) | 1988-04-26 | — | — | US | disclosed |
| US-4269933-A | PHOTOLITHOGRAPHY; POSITIVE AND NEGATIVE IMAGES; POLYMERIZATION OF A UNSATURATED POLYESTER USING A PHOTOSENSITIVE FREE RADICAL SYSTEM | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-05-26 | — | — | US | disclosed |
| US-4198242-A | Photopolymerizable composition containing an o-nitroaromatic compound as photoinhibitor | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062400-A1 | SYSTEMS AND METHODS FOR THE SYNTHESIS OF HYDROXAMIC ACIDS | HPSE, HMOX1, HAO2 | LMNA 1399/4885KMT2A 868/4885MEN1 2681/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.